pancreatitis from tirzepatide Researchers Describe Cases of With Tirzepatide in Type 2 Diabetes:

The 2024 FDA approval of resmetirom, the first targeted therapy for MASLD/MASH, represents a significant advancement (88)

The beneficial effects of EPO in patients with toxic damage to the optic nerve secondary to methanol exposure are particularly presumed to be due to its ability to inhibit axon and RGC apoptosis, as well as the anti-oxidant activity exerted by an increase in the activity of two key enzymes in the anti-oxidant defense systemGSH and SOD (Pakravan et al

Thymosin beta 4: actin-sequestering protein functions in cell migration and wound repair

Circulation Arrhythmia and electrophysiology

Direct force can disrupt peptide bond integrity in fragile sequences